NCT06116357View on ClinicalTrials.gov

The Safety and Efficacy of Carotid Body Modulation Therapy in Hypertensive Patients by External Ultrasonic Micro-bubble

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

September 1, 2026

Study Completion Date

December 30, 2026

Conditions
Primary Hypertension
Interventions
DEVICE

External Ultrasonic Micro-bubble

The enrollmented hypertensive patients should aceepted CB modulation therapy by external ultrasonic micro-bubble

Trial Locations (1)

400010

The Second Affilated Hospital of Chongqing Medical Universty, Chongqing

All Listed Sponsors
collaborator

The Second Affiliated Hospital of Chongqing Medical University

OTHER

lead

Jing Huang

OTHER

NCT06116357 - The Safety and Efficacy of Carotid Body Modulation Therapy in Hypertensive Patients by External Ultrasonic Micro-bubble | Biotech Hunter | Biotech Hunter